Le Lézard
Classified in: Health
Subjects: PDT, MAT

Trulieve Opening Medical Cannabis Dispensary in Marianna, Florida


Company celebrates grand opening, improves patient access in Florida's north panhandle

TALLAHASSEE, Fla., Oct. 27, 2023 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical dispensary located at 4256 Lafayette Street in Marianna, Florida.

On Saturday, October 28, Trulieve will host a grand opening celebration beginning at 9 a.m. featuring partner giveaways, music, specials, discounts, and opportunities to register for upcoming patient education sessions.

"We are constantly looking for new ways to engage with customers and expand access to cannabis," said Trulieve's Chief Executive Officer Kim Rivers. "This new location makes it easier for patients in the Marianna community to enjoy our superior customer service and top-quality products."

Located along U.S. Highway 90 and less than five miles from Interstate 10, the new Marianna dispensary offers greater convenience to Florida patients and caregivers in Jackson, Washington, and Calhoun counties.

The new location will offer a wide variety of popular products including Trulieve's portfolio of in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk and Trekkers. Customers will also have access to beloved partner brands such as Alien Labs, Binske, Black Tuna, Blue River, Connected Cannabis, DeLisioso, Khalifa Kush, Love's Oven, Miami Mango, O.pen, Seed Junky and Sunshine Cannabis, all available exclusively at Trulieve in Florida.

Trulieve offers statewide home delivery, convenient online ordering, and in-store pickup. Veterans receive 20% off every order when they show their military ID, and all first-time guests are eligible for a 60% new customer discount at any Florida Trulieve location.

The new Marianna dispensary will be open 9 a.m. ? 8:30 p.m. Monday through Saturday and 11 a.m. ? 8 p.m. on Sundays. For more information, or to learn how to become a registered patient, please visit Trulieve.com and connect on Instagram or Facebook.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve   
Instagram: @Trulieve_   
Twitter: @Trulieve 

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
[email protected]

Media Contact
Phil Buck, APR, Corporate Communications Manager
+1 (406) 370-6226
[email protected] 

SOURCE Trulieve Cannabis Corp.


These press releases may also interest you

14 fév 2025
Report with market evolution powered by AI - The global gender reassignment surgery market  size is estimated to grow by USD 374.2 million from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over 11.2%  during the...

14 fév 2025
On the morning of February 14, 2025 (UTC-8), at the ongoing 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) held in San Francisco, USA, Professor Xinan Sheng from Peking University Cancer Hospital delivered the...

14 fév 2025
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZAtm (vimseltinib), a kinase inhibitor, for adult patients with symptomatic...

14 fév 2025
We are accelerating Canada's work to detect, disrupt, and dismantle the fentanyl trade. Illegal drugs are having a devastating impact on people and communities, including creating security challenges associated with their illegal production,...

14 fév 2025
Aurora Cannabis Inc. (the "Company" or "Aurora")  , the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis...

14 fév 2025
OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp. (the "Company")) and OSR Holdings Co., Ltd. ("OSR") announced today the completion of their business combination (the "Business Combination")....



News published on and distributed by: